Context Capital Management, LLC
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationlajolla, CA
- CIK0001301396
- Alternate namesContext Advisory LLC
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
238 | $2.56B | DDD 0 11/15/26, SNAP INC, TDOC 1.25 06/01/27, XMTR 1 02/01/27 | 13F-HR | Feb 11, 2025 | 000130139625000002 | ||
284 | $3.68B | RKLB 4.25 02/01/29, PTON 5.5 12/01/29, SNAP INC, MSTR 0 02/15/27 | 13F-HR | Nov 14, 2024 | 000130139624000010 | ||
222 | $2.78B | SKIN 1.25 10/01/26, DDD 0 11/15/26, W 1 08/15/26, MSTR 0 02/15/27 | 13F-HR | Aug 9, 2024 | 000130139624000007 | ||
277 | $2.10B | SKIN 1.25 10/01/26, PTON 0 02/15/26, MSTR 0 02/15/27, W 1 08/15/26 | 13F-HR | May 2, 2024 | 000130139624000006 | ||
281 | $1.49B | PTON 0 02/15/26, W 1 08/15/26, W 0.625 10/01/25, COIN 0.5 06/01/26 | RESTATEMENT | Feb 16, 2024 | 000130139624000004 | ||
311 | $1.25M | PTON 0 02/15/26, W 0.625 10/01/25, W 1 08/15/26, OMER 6.25 11/15/23 | 13F-HR | Nov 13, 2023 | 000130139623000005 | ||
315 | $1.11M | PTON 0 02/15/26, W 0.625 10/01/25, W 1 08/15/26, FIVN 0.5 06/01/25 | 13F-HR | Aug 10, 2023 | 000130139623000004 | ||
346 | $1.19M | RNG 0 03/01/25, W 0.625 10/01/25, PEGA 0.75 03/01/25, SEALTD 0.25 09/15/26 | 13F-HR | May 8, 2023 | 000130139623000003 | ||
477 | $1.37M | RNG 0 03/01/25, PTON 0 02/15/26, DKNG 0 03/15/28, W 0.625 10/01/25 | 13F-HR | Feb 14, 2023 | 000130139623000002 | ||
594 | $1.49B | RNG 0 03/01/25, PTON 0 02/15/26, W 0.625 10/01/25, SEALTD 0.25 09/15/26 | 13F-HR | Nov 7, 2022 | 000130139622000005 | ||
619 | $1.40B | THERAVANCE BIOPHARMA INC, INFN 2.125 09/01/24, VREX 4 06/01/25, DISH 2.375 03/15/24 | 13F-HR | Aug 3, 2022 | 000130139622000004 | ||
688 | $1.54B | DISH 2.375 03/15/24, THERAVANCE BIOPHARMA INC, SEALTD 0.25 09/15/26, VREX 4 06/01/25 | 13F-HR | May 9, 2022 | 000130139622000003 | ||
554 | $1.28B | 1LIFE HEALTHCARE INC, VREX 4 06/01/25, DISH 2.375 03/15/24, THERAVANCE BIOPHARMA INC | 13F-HR | Feb 9, 2022 | 000130139622000002 | ||
473 | $979.45M | VREX 4 06/01/25, INFN 2.125 09/01/24, THERAVANCE BIOPHARMA INC, DISH 2.375 03/15/24 | 13F-HR | Nov 12, 2021 | 000130139621000006 | ||
526 | $1.08B | VREX 4 06/01/25, INFN 2.125 09/01/24, GRANITE CONSTR INC, VG 1.75 06/01/24 | 13F-HR | Aug 17, 2021 | 000130139621000005 | ||
462 | $1.02B | INFN 2.125 09/01/24, RVNC 1.75 02/15/27, TVTX 2.5 09/15/25, GRANITE CONSTR INC | 13F-HR | May 17, 2021 | 000130139621000003 | ||
261 | $731.20M | EGHT 0.5 02/01/24, INFN 2.125 09/01/24, GRANITE CONSTR INC, FLXN 3.375 05/01/24 | 13F-HR | Feb 12, 2021 | 000130139621000001 | ||
164 | $460.13M | EGHT 0.5 02/01/24, SEA LTD, VNE 4 06/01/24, ICPT 3.25 07/01/23 | 13F-HR | Nov 16, 2020 | 000130139620000004 | ||
105 | $257.13M | INO 6.5 03/01/24, OPK 4.5 02/15/25, ICPT 3.25 07/01/23, CYTK 4 11/15/26 | 13F-HR | Aug 11, 2020 | 000130139620000003 | ||
101 | $176.19M | INO 6.5 03/01/24, HYG, NH 5.5 12/15/21, IQ 3.75 12/01/23 | 13F-HR | May 12, 2020 | 000130139620000002 | ||
100 | $199.55M | COVPHA 3.25 06/01/22, IQ 3.75 12/01/23, THERAVANCE BIOPHARMA INC, OPK 4.5 02/15/25 | 13F-HR | Feb 7, 2020 | 000130139620000001 | ||
91 | $176.44M | PDLI 2.75 12/01/24, TISI 5 08/01/23, COVPHA 3.25 06/01/22, IQIYI INC | 13F-HR | Nov 1, 2019 | 000130139619000007 | ||
92 | $172.41M | COVPHA 3.25 06/01/22, PDLI 2.75 12/01/21, OPK 4.5 02/15/25, TISI 5 08/01/23 | 13F-HR | Aug 14, 2019 | 000130139619000006 | ||
86 | $164.01M | TIBERIUS ACQUISITION CORP, PDLI 2.75 12/01/21, COVPHA 3.25 06/01/22, IQIYI INC | 13F-HR | May 13, 2019 | 000130139619000005 | ||
80 | $177.04M | PDLI 2.75 12/01/21, COVPHA 3.25 06/01/22, RH 0 06/15/19, TWO 6.25 01/15/22 | 13F-HR | Feb 13, 2019 | 000156761919003519 | ||
69 | $171.94M | COVPHA 3.25 06/01/22, RH 0 06/15/19, TWO 6.25 01/15/22, THERAVANCE BIOPHARMA INC | 13F-HR | Mar 4, 2019 | 000130139619000004 | ||
44 | $116.30M | COVPHA 3.25 06/01/22, REGI 4 06/15/36, PDLI 2.75 12/01/21, THERAVANCE BIOPHARMA INC | 13F-HR | Aug 13, 2018 | 000156761918000545 | ||
51 | $137.79M | PDLI 2.75 12/01/21, COVPHA 3.25 06/01/22, CSV 2.75 03/15/21, SPY | 13F-HR | May 14, 2018 | 000114036118023356 | ||
45 | $168.31M | LGIH 4.25 11/15/19, PDLI 2.75 12/01/21, TWO 6.25 01/15/22, CSV 2.75 03/15/21 | 13F-HR | Feb 13, 2018 | 000114036118006992 | ||
41 | $149.45M | LGIH 4.25 11/15/19, TTMI 1.75 12/15/20, PDLI 2.75 12/01/21, TWO 6.25 01/15/22 | 13F-HR | Nov 17, 2017 | 000114036117043176 | ||
40 | $140.62M | TTMI 1.75 12/15/20, LGIH 4.25 11/15/19, PDLI 2.75 12/01/21, TSLA 1.25 03/01/21 | 13F-HR | Aug 14, 2017 | 000114036117031984 | ||
38 | $125.08M | TTMI 1.75 12/15/20, LGIH 4.25 11/15/19, PDLI 2.75 12/01/21, CSV 2.75 03/15/21 | 13F-HR | May 12, 2017 | 000114036117020039 | ||
32 | $91.27M | ELGX 3.25 11/01/20, LGIH 4.25 11/15/19, PDLI 2.75 12/01/21, AMRI 2.25 11/15/18 | 13F-HR | Feb 14, 2017 | 000114036117006803 | ||
32 | $102.88M | ELGX 3.25 11/01/20, MENT 4 04/01/31, VRSN 3.25 08/15/37, AMRI 2.25 11/15/18 | 13F-HR | Nov 14, 2016 | 000114036116086202 | ||
36 | $86.07M | MENT 4 04/01/31, WFRD 5.875 07/01/21, ELGX 3.25 11/01/20, PDLI 4 02/01/18 | RESTATEMENT | Aug 18, 2016 | 000114036116077122 | ||
47 | $80.44M | AMRI 2.25 11/15/18, AFFX 4 07/01/19, CKH 2.5 12/15/27, PDLI 4 02/01/18 | 13F-HR | Apr 26, 2016 | 000114036116062069 | ||
41 | $64.20M | CKH 2.5 12/15/27, VGR V1.75 04/15/20, AFFX 4 07/01/19, ELGX 3.25 11/01/20 | 13F-HR | Feb 4, 2016 | 000114036116050286 | ||
37 | $54.90M | AFFX 4 07/01/19, VGR V1.75 04/15/20, CKH 2.5 12/15/27, SQNM 5 01/01/18 | 13F-HR | Nov 17, 2015 | 000114036115042050 | ||
35 | $57.77M | AFFX 4 07/01/19, SQNM 5 01/01/18, VGR V1.75 04/15/20, PDLI 4 02/01/18 | 13F-HR | Jul 15, 2015 | 000114036115027604 | ||
35 | $55.17M | AFFX 4 07/01/19, SQNM 5 10/01/17, VGR V1.75 04/15/20, BCOR 4.25 04/01/19 | 13F-HR | Apr 28, 2015 | 000114036115016579 | ||
40 | $80.47M | GARNERO GROUP ACQUISITION CO, AFFX 4 07/01/19, QNMA, BCOR 4.25 04/01/19 | RESTATEMENT | Feb 17, 2015 | 000114036115007471 |